https://www.bloomedi.com/ko/media/body/jw-pharmaceutical-files-korean-phase-3-plan-for-bofanglutide-a59008 MediIndex ko 2026-08-23T10:38:21.731Z JW중외제약, 2주 1회 비만약 보팡글루타이드 국내 3상 신청 https://www.bloomedi.com/en/media/body/jw-pharmaceutical-files-korean-phase-3-plan-for-bofanglutide-a59008 MediIndex en 2026-08-23T10:38:21.731Z JW Pharmaceutical Files Korean Phase 3 Plan for Bofanglutide https://www.bloomedi.com/ko/media/skin/medytox-centers-coretox-at-two-august-medical-forums-3f4dc8 MediIndex ko 2026-08-23T10:37:12.350Z 메디톡스, 8월 두 의료 학술행사에서 코어톡스 임상 논의 확대 https://www.bloomedi.com/en/media/skin/medytox-centers-coretox-at-two-august-medical-forums-3f4dc8 MediIndex en 2026-08-23T10:37:12.350Z Medytox Centers Coretox at Two August Medical Forums https://www.bloomedi.com/ko/media/skin/chong-kun-dang-bio-files-china-application-for-cu-20101-814c22 MediIndex ko 2026-08-23T10:36:02.341Z 종근당바이오 보툴리눔 톡신 CU-20101 중국 품목허가 신청 https://www.bloomedi.com/en/media/skin/chong-kun-dang-bio-files-china-application-for-cu-20101-814c22 MediIndex en 2026-08-23T10:36:02.341Z Chong Kun Dang Bio Files China Application for CU-20101 https://www.bloomedi.com/ko/media/eye/kim-tae-woo-wins-myunggok-clinical-medicine-award-e81712 MediIndex ko 2026-08-23T08:36:07.839Z 김태우 교수, 제5회 김안과병원 명곡 임상의학상 본상 수상 https://www.bloomedi.com/en/media/eye/kim-tae-woo-wins-myunggok-clinical-medicine-award-e81712 MediIndex en 2026-08-23T08:36:07.839Z Kim Tae-woo Wins Myunggok Clinical Medicine Award https://www.bloomedi.com/ko/media/skin/pharmaresearch-shares-everwrinkle-rentox-combination-strategy-b47f48 MediIndex ko 2026-08-23T08:35:20.016Z 파마리서치, 에버클·리엔톡 병행 시술 전략 공유 https://www.bloomedi.com/en/media/skin/pharmaresearch-shares-everwrinkle-rentox-combination-strategy-b47f48 MediIndex en 2026-08-23T08:35:20.016Z PharmaResearch Shares Everwrinkle-ReNTox Combination Strategy https://www.bloomedi.com/ko/media/eye/eye-society-urges-safety-rules-before-telemedicine-launch-3a9863 MediIndex ko 2026-08-23T08:34:31.103Z 대한안과의사회, 비대면 안과진료 시행 전 안전기준 마련 촉구 https://www.bloomedi.com/en/media/eye/eye-society-urges-safety-rules-before-telemedicine-launch-3a9863 MediIndex en 2026-08-23T08:34:31.103Z Eye Society Urges Safety Rules Before Telemedicine Launch https://www.bloomedi.com/ko/media/skin/medytox-q2-revenue-rises-11-4-as-filler-sales-grow-17f979 MediIndex ko 2026-08-23T06:39:08.429Z 메디톡스 2분기 매출 11.4% 증가, 필러 판매 성장 https://www.bloomedi.com/en/media/skin/medytox-q2-revenue-rises-11-4-as-filler-sales-grow-17f979 MediIndex en 2026-08-23T06:39:08.429Z Medytox Q2 Revenue Rises 11.4% as Filler Sales Grow https://www.bloomedi.com/ko/media/eye/sudden-vision-loss-and-limb-weakness-may-signal-ms-ee10ca MediIndex ko 2026-08-23T06:38:05.903Z 젊은층 갑작스러운 시력 저하와 팔다리 힘 빠짐, 다발성경화증 신호일 수 있어 https://www.bloomedi.com/en/media/eye/sudden-vision-loss-and-limb-weakness-may-signal-ms-ee10ca MediIndex en 2026-08-23T06:38:05.903Z Sudden Vision Loss and Limb Weakness May Signal MS https://www.bloomedi.com/ko/media/breast/korean-breast-groups-set-guidance-for-mammotome-use-afdd8b MediIndex ko 2026-08-23T06:36:57.308Z 유방 혹 맘모톰 시술, 한국유방암학회가 적용 권고안 마련 https://www.bloomedi.com/en/media/breast/korean-breast-groups-set-guidance-for-mammotome-use-afdd8b MediIndex en 2026-08-23T06:36:57.308Z Korean Breast Groups Set Guidance for Mammotome Use https://www.bloomedi.com/ko/media/eye/under-eye-fat-repositioning-depends-on-bulging-and-sagging-2b60a3 MediIndex ko 2026-08-22T20:36:01.681Z 눈밑 불룩함·꺼짐, 지방재배치와 하안검 선택 기준은 https://www.bloomedi.com/en/media/eye/under-eye-fat-repositioning-depends-on-bulging-and-sagging-2b60a3 MediIndex en 2026-08-22T20:36:01.681Z Under-Eye Fat Repositioning Depends on Bulging and Sagging